Jeff Bezos sells roughly £1.6bn of Amazon shares February 11, 2024 Amazon founder Jeff Bezos has sold around 12m shares of the online retail and cloud services firm for roughly $2bn (£1.6bn).
I feel ‘personally responsible’ for the UK economy says BT boss February 8, 2024 The weight of keeping British businesses up and running is a heavy one according to the boss of BT’s business unit, Bas Burger.
‘About a third’ of Facebook Marketplace listings could be scams, MPs told February 7, 2024 A director at TSB Bank has warned a group of top MPs that Facebook Marketplace and cryptocurrency investment are major breeding grounds for scams amid calls for Big Tech to take more responsibility for a wave of fraud on social media.
‘Huge potential’ for City says UK science minister amid soaring UK quantum investment February 7, 2024 Investment into quantum computing has "huge potential" for London, according to the UK's science minister, Andrew Griffith.
How social media giant Snap has been snapped back to reality February 7, 2024 Like its vanishing photos, Snapchat itself is facing up to fears it might too be just a momentary diversion.
Has ChatGPT single-handedly killed the world’s chances of hitting net zero? February 6, 2024 When questioned if it really did have our best intentions at heart, ChatGPT is unnervingly diplomatic.
TalkTalk buys half-a-million Shell Energy customers in deal with Octopus February 6, 2024 TalkTalk has bought almost 500,000 Shell Energy customers in a deal with Octopus Energy.
Renishaw share price soars despite profit plunging for British manufacturer February 6, 2024 The firm added it had "undertaken a targeted mutually agreed severance scheme in the UK to allow employees to voluntarily leave the company"
Palantir: US tech firm with lucrative NHS contract sees AI sales soar February 6, 2024 Shares in US tech firm Palantir have jumped nearly 18 per cent demand for artificial intelligence (AI) has driven sales higher.
GSK announces breakthrough with blood cancer treatment drug Blenrep February 6, 2024 Biotech giant GSK has announced a potential breakthrough in the treatment of relapsed or refractory multiple myeloma, a type of blood cancer.